When to sell your mutual fund? Here’s how to decide

Equity mutual fund investors often attempt to time the market. This strategy involves waiting for market declines to purchase shares at lower prices, with the intention of maximizing profits by selling at higher prices. While the principle of buying low and selling high is widely regarded as the optimal investment strategy, its execution is considerably challenging.

The stock market is inherently volatile, making it difficult to accurately identify the lowest and highest points. Occasionally, as the market reaches new peaks and stock valuations rise, some investors may feel compelled to realize their profits. While this approach is not inherently flawed, adhering to fundamental investment principles can be beneficial. It is essential to adopt a prudent strategy regarding the sale of mutual fund units or the decision to exit investments.

For mutual fund investors, there is no definitive moment deemed ideal for exiting. The notion that one can time the market implies the ability to predict optimal exit points, which is generally discouraged. It is advisable to adhere to the well-known principle of remaining invested in the market over time. Nonetheless, there may be legitimate circumstances that necessitate accessing funds from the market. Let us examine some of these situations.

Also Read: SIP Calculator: How much can you earn by investing Rs 5000 or Rs 10000 monthly over 10 years?

Are your goals approaching?

If your financial goals are approaching, it is prudent to transition from equity funds to less-volatile liquid funds through a process known as de-risking. For long-term objectives, such as funding education or retirement, it is advisable to divest from equity funds well ahead of the investment horizon, ideally two to three years in advance. Even if there is a slight shortfall in returns of approximately 6-7%, liquid funds can effectively bridge the gap for the remaining duration of your investment timeline for these goals. Short-term objectives or those that are imminent should be directly addressed with liquid mutual fund investments, rather than being left vulnerable to the fluctuations of equity markets.

Fund Performance

It is essential to conduct regular evaluations of your mutual fund scheme’s performance. While certain funds may consistently exceed expectations, many actively-managed funds may underperform relative to the market or their benchmarks. If, during your review, you identify underperforming funds within your portfolio, it may be prudent to consider divesting from them.

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s